Decoy Therapeutics (FP11) Q2 2024 Earnings Report
DE:FP11 Q2 2024 EPS Results
- Actual EPS
- -EUR 2.05
- Consensus EPS
- -EUR 46.38
- Beat/Miss
- Beat by +EUR 44.33
- One Year Ago EPS
- -EUR 9.90
DE:FP11 Q2 2024 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/07/2024
- Time
- TBA
- Conference Call
- Wednesday, August 7, 2024
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:FP11 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 30, 2026 | 2025 (Q4) | ―- | -0.88 | ― | |
| Aug 06, 2025 | 2025 (Q2) | ―-5.86 | -30.79 | 80.98% (+24.94) | |
| May 08, 2025 | 2025 (Q1) | ―-0.89 | -0.35 | -150.49% (-0.53) | |
| Mar 24, 2025 | 2024 (Q4) | ―-13.18 | -22.84 | 42.28% (+9.66) | |
| Aug 07, 2024 | 2024 (Q2) | -46.38-2.05 | -9.9 | 79.28% (+7.85) | |
| May 09, 2024 | 2024 (Q1) | -5.80- | -1.93 | ― | |
| Mar 22, 2024 | 2023 (Q4) | -69.57-22.84 | -293.85 | 92.23% (+271.01) | |
| Nov 15, 2023 | 2023 (Q3) | -0.80-0.56 | -5.55 | 89.86% (+4.98) | |
| Aug 10, 2023 | 2023 (Q2) | -134.64-148.48 | -233.63 | 36.44% (+85.15) | |
| May 11, 2023 | 2023 (Q1) | -259.59-231.84 | -337.47 | 31.30% (+105.62) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
